BioLife Solutions (BLFS) Tops Q3 EPS by 4c, Beats on Revenue; Offers FY24 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $38.61 --0%
EPS Growth %: +400.0%
Financial Fact:
General and administrative: 1.04M
Today's EPS Names:
COHR, ATS, SICP, More
EPS Growth %: +400.0%
Financial Fact:
General and administrative: 1.04M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $30.57 million versus the consensus estimate of $25.54 million.
GUIDANCE:
BioLife Solutions sees FY2024 revenue of $98-100 million, versus the consensus of $110.6 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Real Industry (RELY) Tops Q3 EPS by 15c; offers guidance
- Suncor Energy (SU) Tops Q3 EPS by 172c
- Deluxe Corp. (DLX) Tops Q3 EPS by 11c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
